hello. i am new to GRACE. my husband got nsclc in feb of 2009. it was stage 3. he had the upper right lobe removed then chemo then radiation. he had a stable plueral effusion that became encapsulated. in november of 2010 it cancer came back and he developed malignant plueral effusion. they drained 2 liters. it also spread to his bones and the left lung had too many tumors to count.
he started on Tarceva in december on 2010 and by feb everything was gone (except the stable pleural effusion). his scans were good but his CEA started rising in july of 2011. we went the the university of chicago to see if a trial for a tarceva booster was available. he didnt qualify because he needed at least 20% progression. Dr Salgia said to not even take CEA tests as they are not reliable. our dr kept taking and the numbers kept rising. the last we saw was in oct of 2011 and it was over 280. he did very well until the scan in june 2012. that showed "new mild to moderate nodularity along the omentum and mesentery, concerning for metastatic disease". the dr said to watch and see. then oct 2012 the scan said "increasing mesenteric carcinomatosis" and our dr recommended a biospy. we had the biospy and now we heard it is positive for mets.
before we got the results dr said we could try to get into a trail for a tarceva booster or start Alimta. casey was egfr positive. i am wondering if he would not be a good canditate for Lucinix or Crizotinib, or even Tarceva pulsing. i dont know if i should mention these things to the dr or just assume he has thought of them.
DO YOU THINK MY HUSBAND WOULD BE A GOOD CANDIDATE FOR THESE TREATMENTS. and also, IS THIS USUALLY A SIGNAL THAT THE CANCER IS SO WIDESPREAD THAT HE DOES NOT HAVE MUCH OF A CHANCE, SINCE IT SPREAD TO SUCH A DISTANT SITE?
Thank you so much